Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...

Sub-Saharan Africa remains the epicenter of the AIDS pandemic. Trump's cuts have restricted the availability of drugs that millions of Africans have taken to prevent infection - particularly ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

These are the words of Rogers Omollo, founder and CEO of Activate Action – a youth-led non-profit organisation that supports ...

The initiative, first to be launched in the country, is aimed at having men and boys as champions to eliminate new HIV infections and AIDS deaths.

The World Health Organization (WHO) has issued a grave warning about an imminent HIV drug shortage in several countries ...

Kenya is among nine African countries selected to introduce Lenacapavir, a groundbreaking long-acting injectable HIV ...

The World Health Organization has approved the rollout of an injectable HIV preventive drug; Lenacapavir or LEN. The National ...

If we are going to defeat HIV, we cannot abandon our commitment to fully fund research, and we cannot walk away from our work to treat and prevent the disease.

Recently, Kenya launched the National Multisectoral HIV Prevention Acceleration Plan 2023-2030 to eliminate new HIV infections by 2030.

HIV prevention is evolving, with new strategies targeting disparities and improving access.